Unknown PHASE3 INTERVENTIONAL 3-arm NCT03134157

The Effect of Simvastatin on Uterine Leiomyoma Development and Growth in Infertile Women

Evaluation the Effect of Simvastatin on Uterine Leiomyoma Development and Growth in Infertile Patients

Sponsor: Royan Institute

Interventions Vaginal placebo+ oral placebo oral drug and oral placebo oral drug and vaginal placebo

Updated 8 times since 2017 Last updated: Oct 5, 2020 Started: Aug 31, 2016 Primary completion: Jun 14, 2021 Completion: Sep 14, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Infertility and is currently ongoing. Royan Institute leads this study, which shows 8 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Nov 2022 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jan 2021 — Nov 2022 [monthly]

Recruiting PHASE3

▶ Show 3 earlier versions

Nov 2020 — Jan 2021 [monthly]

Recruiting PHASE3

Status: Unknown Status → Recruiting
Sep 2019 — Nov 2020 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
May 2017 — Sep 2019 [monthly]

Recruiting PHASE3

First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Royan Institute

Data source: Royan Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tehrān, Iran